In Japan, Pfizer Is Short of Drug to Help Smokers

After a rise in the cigarette tax, demand for a Pfizer antismoking drug outstripped the supply.

In Japan, Pfizer Is Short of Drug to Help Smokers

Backlink: http://feeds.nytimes.com/click.phdo?i=a938dbb60c25bc0d27765b1c25da0693

Pfizer to Pay Its Ex-Chief $4.5 Million in Severance

In total, Jeffrey B. Kindler, who resigned unexpectedly as chief executive and chairman, will receive $9.5 million in cash in addition to stock and retirement benefits.

Pfizer to Pay Its Ex-Chief $4.5 Million in Severance

Backlink: http://feeds.nytimes.com/click.phdo?i=103a077732fe1d7d601b85bbc4733b03

Pfizer Chief Steps Down Unexpectedly

Jeffrey B. Kindler, the head of the world’s biggest drugmaker, Pfizer Inc., has stepped down unexpectedly after less than five years at the helm.

Pfizer Chief Steps Down Unexpectedly

Backlink: http://feeds.nytimes.com/click.phdo?i=67e8d86a89b76b49a30009dc8e300308

Pfizer Plans $75 Million Fund to Address Shareholder Suits

In a preliminary settlement agreement, Pfizer tries to address lawsuits accusing its board and top officials of failing to stop illegal marketing of its drugs.

Pfizer Plans $75 Million Fund to Address Shareholder Suits

Backlink: http://feeds.nytimes.com/click.phdo?i=2122e99ec40955c72760e20e1132141a